PHARMACYCLICS INC 4
4 · PHARMACYCLICS INC · Filed Mar 6, 2014
Insider Transaction Report
Form 4
Sjovall Boultbee Paula S
EVP, Sales and Marketing
Transactions
- Exercise/Conversion
Common Stock
2014-03-04$25.94/sh+13,747$356,597→ 15,486 total - Sale
Common Stock
2014-03-04$137.07/sh−13,747$1,884,330→ 1,739 total - Sale
Common Stock
2014-03-05$140.75/sh−6,253$880,115→ 1,739 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-03-05−6,253→ 180,000 totalExercise: $25.94From: 2012-04-17Exp: 2022-04-17→ Common Stock (6,253 underlying) - Exercise/Conversion
Common Stock
2014-03-05$25.94/sh+6,253$162,203→ 7,992 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-03-04−13,747→ 186,253 totalExercise: $25.94From: 2012-04-17Exp: 2022-04-17→ Common Stock (13,747 underlying)
Holdings
- 406(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]The option shares vest 25% on each of April 11, 2013, April 11, 2014, April 11, 2015 and April 11, 2016, subject to satisfaction of certain performance criteria with respect to each vesting period. Such performance criteria is to be determined and approved by the Compensation Committee.